Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study.
Atsunori Nakao, Yoshiya Toyoda, Prachi Sharma, Malkanthi Evans, Najla Guthrie · Journal of clinical biochemistry and nutrition · 2010
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In 20 participants with potential metabolic syndrome, further, subjects demonstrated an 8% increase in high density lipoprotein (HDL)-cholesterol and a 13% decrease in total cholesterol/HDL-cholesterol from baseline to week 4., drinking hydrogen rich water represents a potentially novel therapeutic and preventive strategy for metabolic syndrome. These findings add human evidence supporting molecular hydrogen's therapeutic potential for metabolic syndrome.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water affected the outcomes measured in 20 participants with potential metabolic syndrome. Further, subjects demonstrated an 8% increase in high density lipoprotein (HDL)-cholesterol and a 13% decrease in total cholesterol/HDL-cholesterol from baseline to week 4., drinking hydrogen rich water represents a potentially novel therapeutic and preventive strategy for metabolic syndrome.
What the Researchers Studied
The researchers studied 20 participants with potential metabolic syndrome. The study used a human clinical study.
What Effects Did Molecular Hydrogen Have?
The portable magnesium stick was a safe, easy and effective method of delivering hydrogen rich water for daily consumption by participants in the study. Further, subjects demonstrated an 8% increase in high density lipoprotein (HDL)-cholesterol and a 13% decrease in total cholesterol/HDL-cholesterol from baseline to week 4., drinking hydrogen rich water represents a potentially novel therapeutic and preventive strategy for metabolic syndrome.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential for metabolic syndrome and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a human clinical study. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The research population or model was 20 participants with potential metabolic syndrome. The reported sample size was 20. The study used a human clinical study. The hydrogen delivery method was hydrogen-rich water.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.